Medicinal Cannabis for Gastrointestinal Disorders: Evidence and Recommendations

Join Dr. Scott Smid, Senior Lecturer at the University of Adelaide, as we explore the therapeutic potential of medicinal cannabis in managing gastrointestinal disorders, with a particular focus on inflammatory bowel disease (IBD) and some aspects of irritable bowel syndrome (IBS). These conditions highlight the critical need for effective treatments. Discover how cannabinoids can modulate inflammation and gut motility, potentially enhancing patient outcomes. Gain insights into general dosing strategies and the variety of administration methods, emphasising the importance of patient education in effective cannabinoid therapy. While the session will not provide detailed dosing guidelines for specific GI conditions, it will offer a broad overview informed by Dr. Smid's preclinical research. This approach aims to make complex scientific information accessible, enhancing understanding without diluting the impact of the core topics.